Cargando…
EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides
The skeleton is the most common metastatic site in patients with advanced cancer. Pain is a major healthcare problem in patients with bone metastases. Bone-seeking radionuclides that selectively accumulate in the bone are used to treat cancer-induced bone pain and to prolong survival in selected gro...
Autores principales: | Handkiewicz-Junak, Daria, Poeppel, Thorsten D., Bodei, Lisa, Aktolun, Cumali, Ezziddin, Samer, Giammarile, Francesco, Delgado-Bolton, Roberto C., Gabriel, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978928/ https://www.ncbi.nlm.nih.gov/pubmed/29453701 http://dx.doi.org/10.1007/s00259-018-3947-x |
Ejemplares similares
-
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
por: Zaknun, John J., et al.
Publicado: (2013) -
EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision
por: Verberne, Hein J., et al.
Publicado: (2015) -
EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases
por: Aarntzen, Erik H. J. G., et al.
Publicado: (2021) -
The EANM practice guidelines for bone scintigraphy
por: Van den Wyngaert, T., et al.
Publicado: (2016) -
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
por: Weber, M., et al.
Publicado: (2022)